Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748144 · ClinicalTrials.gov registry record · Phase 2
IO Vancomycin Spine
A Phase 2 study, sponsored by The Methodist Hospital Research Institute.
- Not yet
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT06748144: Clinical Trial Phase 2 study, sponsored by The Methodist Hospital Research Institute.
NCT06748144 is a Phase 2 study that has not yet begun recruiting, run by The Methodist Hospital Research Institute. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06748144, a Phase 2 study, has not yet begun recruiting, sponsored by The Methodist Hospital Research Institute.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.
Primary Outcome
The level of vancomycin concentration will be assessed via a blood draw by the anesthesiologist staff.
Interventions
- DRUG Intravenous Vancomycin
- DRUG Intraosseous Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05 |
| Est. Completion | 2030-04 |
| Phase | Phase 2 |
What is known before NCT06748144 opens enrollment
NCT06748144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Intravenous Vancomycin is the first listed.
NCT06748144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06748144 about?
NCT06748144 is a clinical study titled "IO Vancomycin Spine". The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusio...
What is the current status of trial NCT06748144?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-05. Estimated completion is 2030-04.
What interventions are being tested in trial NCT06748144?
The interventions under investigation include: Intravenous Vancomycin (DRUG), Intraosseous Vancomycin (DRUG).
Who is sponsoring clinical trial NCT06748144?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06748144's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia